0	7	Control	Control	NNP
8	10	of	of	IN
11	19	NF-kappa	NF-kappa	NNP
20	21	B	B	NNP
22	30	activity	activity	NN
31	33	by	by	IN
34	37	the	the	DT
38	39	I	i	NN
40	45	kappa	kappa	NN
46	47	B	B	NNP
48	52	beta	beta	NN
53	62	inhibitor	inhibitor	NN
62	63	.	.	.

65	68	The	the	DT
69	82	transcription	transcription	NN
83	89	factor	factor	NN
90	98	NF-kappa	NF-kappa	NNP
99	100	B	B	NNP
101	103	is	be	VBZ
104	114	maintained	maintain	VBN
115	117	in	in	IN
118	120	an	an	DT
121	129	inactive	inactive	JJ
130	141	cytoplasmic	cytoplasmic	JJ
142	147	state	state	NN
148	150	by	by	IN
151	152	I	i	NN
153	158	kappa	kappa	NN
159	160	B	B	NNP
161	171	inhibitors	inhibitor	NNS
171	172	.	.	.

173	175	In	in	IN
176	185	mammalian	mammalian	JJ
186	191	cells	cell	NNS
191	192	,	,	,
193	194	I	i	NN
195	200	kappa	kappa	NN
201	202	B	B	NNP
203	208	alpha	alpha	NN
209	212	and	and	CC
213	214	I	i	NN
215	220	kappa	kappa	NN
221	222	B	B	NNP
223	227	beta	beta	NN
228	236	proteins	protein	NNS
237	241	have	have	VBP
242	246	been	be	VBN
247	255	purified	purify	VBN
256	259	and	and	CC
260	265	shown	show	VBN
266	268	to	to	TO
269	271	be	be	VB
272	275	the	the	DT
276	286	inhibitors	inhibitor	NNS
287	289	of	of	IN
290	298	NF-kappa	NF-kappa	NNP
299	300	B	B	NNP
301	308	through	through	IN
309	314	their	their	PRP$
315	326	association	association	NN
327	331	with	with	IN
332	335	the	the	DT
336	339	p65	p65	NN
340	342	or	or	CC
343	348	c-Rel	c-rel	NN
349	357	subunits	subunit	NNS
357	358	.	.	.

359	361	In	in	IN
362	370	addition	addition	NN
370	371	,	,	,
372	374	we	we	PRP
375	379	have	have	VBP
380	388	isolated	isolate	VBN
389	390	a	a	DT
391	396	third	third	JJ
397	405	NF-kappa	NF-kappa	NNP
406	407	B	B	NNP
408	417	inhibitor	inhibitor	NN
417	418	,	,	,
419	420	I	i	NN
421	426	kappa	kappa	NN
427	428	B	B	NNP
429	436	epsilon	epsilon	NN
437	438	(	(	(
438	439	1	1	CD
439	440	)	)	)
440	441	.	.	.

442	446	Upon	upon	IN
447	456	treatment	treatment	NN
457	461	with	with	IN
462	463	a	a	DT
464	469	large	large	JJ
470	477	variety	variety	NN
478	480	of	of	IN
481	489	inducers	inducer	NNS
489	490	,	,	,
491	492	I	i	NN
493	498	kappa	kappa	NN
499	500	B	B	NNP
501	506	alpha	alpha	NN
506	507	,	,	,
508	509	I	i	NN
510	515	kappa	kappa	NN
516	517	B	B	NNP
518	522	beta	beta	NN
523	526	are	be	VBP
527	542	proteolytically	proteolytically	RB
543	551	degraded	degrade	VBN
551	552	,	,	,
553	562	resulting	result	VBG
563	565	in	in	IN
566	574	NF-kappa	NF-kappa	NNP
575	576	B	B	NNP
577	590	translocation	translocation	NN
591	595	into	into	IN
596	599	the	the	DT
600	607	nucleus	nucleus	NN
607	608	.	.	.

609	613	Here	here	RB
614	616	we	we	PRP
617	621	show	show	VBP
622	626	that	that	IN
627	629	in	in	IN
630	635	E29.1	e29.1	NN
636	637	T	t	NN
638	642	cell	cell	NN
643	652	hybridoma	hybridoma	NN
653	654	I	i	NN
655	660	kappa	kappa	NN
661	662	B	B	NNP
663	668	alpha	alpha	NN
669	672	and	and	CC
673	674	I	i	NN
675	680	kappa	kappa	NN
681	682	B	B	NNP
683	687	beta	beta	NN
688	691	are	be	VBP
692	699	equally	equally	RB
700	710	associated	associate	VBN
711	715	with	with	IN
716	719	p65	p65	NN
720	723	and	and	CC
724	728	that	that	IN
729	730	I	i	NN
731	736	kappa	kappa	NN
737	738	B	B	NNP
739	743	beta	beta	NN
744	746	is	be	VBZ
747	755	degraded	degrade	VBN
756	758	in	in	IN
759	767	response	response	NN
768	770	to	to	TO
771	774	TNF	TNF	NNP
775	780	alpha	alpha	NN
781	783	in	in	IN
784	792	contrast	contrast	NN
793	795	to	to	TO
796	800	what	what	WP
801	804	has	have	VBZ
805	809	been	be	VBN
810	820	originally	originally	RB
821	830	published	publish	VBN
830	831	.	.	.

832	835	Our	our	PRP$
836	840	data	datum	NNS
841	845	also	also	RB
846	853	suggest	suggest	VBP
854	858	that	that	IN
858	859	,	,	,
860	866	unlike	unlike	IN
867	868	I	i	NN
869	874	kappa	kappa	NN
875	876	B	B	NNP
877	882	alpha	alpha	NN
882	883	,	,	,
884	885	I	i	NN
886	891	kappa	kappa	NN
892	893	B	B	NNP
894	898	beta	beta	NN
899	901	is	be	VBZ
902	916	constitutively	constitutively	RB
917	931	phosphorylated	phosphorylate	VBN
932	935	and	and	CC
936	949	resynthesized	resynthesize	VBN
950	952	as	as	IN
953	954	a	a	DT
955	973	hypophosphorylated	hypophosphorylate	VBN
974	978	form	form	NN
978	979	.	.	.

980	983	The	the	DT
984	991	absence	absence	NN
992	994	of	of	IN
995	999	slow	slow	JJ
1000	1009	migrating	migrating	JJ
1010	1015	forms	form	NNS
1016	1018	of	of	IN
1019	1020	I	i	NN
1021	1026	kappa	kappa	NN
1027	1028	B	B	NNP
1029	1033	beta	beta	NN
1034	1043	following	follow	VBG
1044	1055	stimulation	stimulation	NN
1056	1064	suggests	suggest	VBZ
1065	1069	that	that	IN
1070	1073	the	the	DT
1074	1089	phosphorylation	phosphorylation	NN
1090	1094	does	do	VBZ
1095	1098	not	not	RB
1099	1110	necessarily	necessarily	RB
1111	1121	constitute	constitute	VB
1122	1125	the	the	DT
1126	1140	signal-induced	signal-induced	JJ
1141	1146	event	event	NN
1147	1152	which	which	WDT
1153	1160	targets	target	VBZ
1161	1164	the	the	DT
1165	1173	molecule	molecule	NN
1174	1177	for	for	IN
1178	1189	proteolysis	proteolysis	NN
1189	1190	.	.	.